NCT07090499 - A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors | Biotech Hunter

Enrollment

310

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

July 8, 2028

Study Completion Date

July 8, 2029

Conditions

Advanced/Metastatic Solid TumorsBladder CancerUrothelial CarcinomaAdvanced Non-Small Cell Lung CancerCarcinoma, Non Small Cell LungCarcinoma, Squamous Cell of Head and NeckHead and Neck CancerEsophageal CancerGastroesophageal Junction AdenocarcinomaEsophageal Squamous Cell CarcinomaEsophageal AdenocarcinomaPancreatic AdenocarcinomaPancreatic Cancer

Interventions

DRUG

PF-08046876

Intravenous administration

Trial Locations (2)

78229

RECRUITING

NEXT Oncology, San Antonio

00935

RECRUITING

Pan American Center for Oncology Trials, LLC, Rio Piedras